Guardant Health
GH
#3260
Rank
ยฃ2.84 B
Marketcap
ยฃ23.07
Share price
-3.64%
Change (1 day)
28.07%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Revenue for Guardant Health (GH)

Revenue in 2024 (TTM): ยฃ0.51 Billion

According to Guardant Health 's latest financial reports the company's current revenue (TTM ) is ยฃ0.51 Billion. In 2023 the company made a revenue of ยฃ0.44 Billion an increase over the revenue in the year 2022 that were of ยฃ0.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Guardant Health from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.51 B15.78%
2023 ยฃ0.44 B19.13%
2022 ยฃ0.37 B34.24%
2021 ยฃ0.27 B31.59%
2020 ยฃ0.21 B28.67%
2019 ยฃ0.16 B128.95%
2018 ยฃ71.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ1.07 B 111.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.72 B 41.69%๐Ÿ‡บ๐Ÿ‡ธ USA